Nurix Therapeutics, Inc. issued a press release on July 9, 2026, announcing its financial results for the fiscal quarter ended May 31, 2026. Nurix Therapeutics, Inc. is a biotechnology company focused on developing and commercializing targeted protein degradation therapies.
